Qualitative review highlights barriers to recognizing autism in women with borderline personality disorder diagnoses
Many women with BPD may actually be autistic
This qualitative review synthesizes interviews with 15 clinicians and 15 women or people assigned female at birth regarding autism recogniti…
Hundreds of women told doctors they were misdiagnosed with borderline personality disorder when they may actually be autistic, raising urgen…
FDA Approves Caplyta (lumateperone) for Schizophrenia in Adults
FDA approves Caplyta to treat schizophrenia in adults
FDA approved Caplyta (lumateperone) for treatment of schizophrenia in adults.
The FDA approved Caplyta (lumateperone) for treating schizophrenia in adults.
FDA Approves Mydayis (mixed salts of a single-entity amphetamine) for ADHD in Patients 13 and Older
FDA approves new ADHD drug Mydayis for patients 13 and older
FDA approved Mydayis, a CNS stimulant, for ADHD in patients 13 years and older.
The FDA approved Mydayis, a once-daily stimulant for ADHD in people 13 and older. It can last up to 16 hours, which may cause insomnia. This…
FDA Approves Vyvanse (lisdexamfetamine) for Binge Eating Disorder in Adults
FDA approves Vyvanse to treat binge eating disorder in adults
The FDA approved Vyvanse (lisdexamfetamine) for moderate to severe binge eating disorder (BED) in adults.
The FDA has approved Vyvanse (lisdexamfetamine) for moderate to severe binge eating disorder in adults.
FDA Approves Vyvanse (lisdexamfetamine) for Binge Eating Disorder
FDA approves Vyvanse to treat binge eating disorder in adults
FDA approved Vyvanse (lisdexamfetamine) for moderate to severe binge eating disorder (BED) in adults.
The FDA approved Vyvanse for moderate to severe binge eating disorder in adults. It is a stimulant already used for ADHD. This gives patient…
Perinatal depression prevalence in Ethiopian women ranges from 20.1% to 25.8% based on pooled meta-analysis data
One in four Ethiopian mothers faces depression before and after birth
This umbrella review and meta-analysis examined perinatal depression among women in Ethiopia, pooling data from 15,592 participants.
Nearly one in four mothers in Ethiopia experiences depression, a serious issue that demands immediate attention and better care.
Executive function training reduces anxiety and depression in working adults, CBT app improves workplace well-being
Brain Training App Eases Anxiety and Depression at Work
This randomized controlled trial in 228 working adults with mild-to-moderate depression and anxiety compared app-based executive function tr…
A simple brain training app eased anxiety and depression in workers, while a popular CBT app boosted workplace well-being but didn’t reduce …
Narrative review explores microbiome mechanisms as a promising adjunctive avenue for managing depression, anxiety, bipolar disorder, and schizophrenia
Gut Bacteria Can Change Your Mood
This narrative review examines how microbiome-driven modulation of neurotransmitters, microbial metabolites, immune activation, and vagal ne…
What if the bacteria in your gut could be quietly shaping how you feel every day — and fixing them could ease anxiety or depression?
Non-Randomized Pilot Trial Evaluates Aurora Digital CBT Plus Medication for Generalized Anxiety Disorder
Digital Therapy Adds Relief for Anxiety Patients in Mexico
This pilot, non-randomized clinical trial enrolled 34 adults with generalized anxiety disorder on stable pharmacotherapy.
A new Spanish app helps reduce anxiety worry when used with medicine, but experts say more research is needed before calling it a standard f…
Psychomotor retardation in depression linked to increased Parkinson's risk
Slowed movement in depression signals higher Parkinson disease risk
A retrospective cohort study of 6327 individuals with depression found that those with psychomotor retardation had a 43% higher risk of deve…
Depression with slowed movement links to future Parkinson risk, suggesting physical signs may warn of brain changes years before diagnosis.
Cochrane review finds very low-certainty evidence on liver support systems for acute liver failure mortality
Liver support systems may not reduce death risk in acute liver failure
This Cochrane systematic review evaluates liver support systems versus standard medical care in adults with acute liver failure.
A major review of 681 patients found liver support systems likely offer little to no benefit over standard care for reducing death or seriou…
Electroacupuncture research trends for depression show shifting focus to mechanisms from 2005 to 2025
New maps show how electroacupuncture targets brain chemistry now
This bibliometric and visual analysis reviewed 317 international publications on electroacupuncture for depression from 2005 to 2025.
A new map of global research shows scientists are now focusing on how electroacupuncture changes brain chemistry to treat depression.